Late gadolinium enhancement (LGE), a marker of myocardial damage, can be detected by contrast enhanced-cardiac magnetic resonance imaging within the right ventricle of patients with severe pulmonary hypertension. The extent of LGE relates to RV performanc

K. G. Blyth, T. N. Martin, P. B. Mark, H. J. Dargie, A. J. Peacock (Glasgow, United Kingdom)

Source: Annual Congress 2004 - Recent advances in modern chest imaging and their implications on various clinical problems
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. G. Blyth, T. N. Martin, P. B. Mark, H. J. Dargie, A. J. Peacock (Glasgow, United Kingdom). Late gadolinium enhancement (LGE), a marker of myocardial damage, can be detected by contrast enhanced-cardiac magnetic resonance imaging within the right ventricle of patients with severe pulmonary hypertension. The extent of LGE relates to RV performanc. Eur Respir J 2004; 24: Suppl. 48, 1548

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Right ventricular stroke volume measured by MRI as indicator of treatment outcome and predictor of death in patients with pulmonary hypertension
Source: Annual Congress 2005 - Pulmonary arterial hypertension diagnosis and therapy
Year: 2005


Three dimensional (3D) analysis of septal curvature from cardiac magnetic resonance images to determine pulmonary hypertension severity
Source: Annual Congress 2010 - Pulmonary circulation: clinical aspects
Year: 2010


Right ventricular interaction in pulmonary arterial hypertension
Source: Research Seminar 2008 - The Pulmonary Circulation: Scleroderma-Related Pulmonary Arterial Hypertension
Year: 2008

The value of tools to assess pulmonary arterial hypertension
Source: Eur Respir Rev 2011; 20: 222-235
Year: 2011



NT-proBNP can be used to detect right ventricular systolic dysfunction in pulmonary hypertension
Source: Eur Respir J 2007; 29: 737-744
Year: 2007



Ventricular mass index using magnetic resonance imaging accurately estimates pulmonary artery pressure
Source: Eur Respir J 2002; 20: 1519-1524
Year: 2002



A fully automated cardiac magnetic resonance (CMR) assessment improves the evaluation of patients with pulmonary arterial hypertension (PAH)
Source: Virtual Congress 2021 – Novel imaging analysis methodologies in diffuse lung diseases
Year: 2021


Magnetic resonance in pulmonary arterial hypertension: a noninvasive alternative in the assessment of right ventricular function
Source: Eur Respir J 2002; 20: Suppl. 38, 4s
Year: 2002

Cardiac magnetic resonance imaging for the assessment of the heart and pulmonary circulation in pulmonary hypertension
Source: Eur Respir J 2009; 33: 1454-1466
Year: 2009



NT-proBNP reflects right ventricular structure and function in pulmonary hypertension
Source: Eur Respir J 2006; 28: 1190-1194
Year: 2006



Toxic effect of smoking on right and left heart function assessed by cardiac magnetic resonance.
Source: International Congress 2017 – Smoking and health hazards
Year: 2017

Cardiac magnetic resonance imaging versus echocardiography for assessment of cardiac involvement in pulmonary sarcoidosis
Source: Annual Congress 2012 - Pulmonary circulation and functional lung imaging
Year: 2012


Noninvasive pulmonary vascular imaging by MR
Source: Annual Congress 2005 - PG1 - Basics in chest imaging: pulmonary vasculature
Year: 2005

Clinical evaluation of RV wall stress in pulmonary arterial hypertension: A follow-up study using magnetic resonance imaging
Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension
Year: 2011

Gadofosveset-enhanced lung magnetic resonance imaging to detect ongoing vascular leak in pulmonary fibrosis
Source: Eur Respir J, 51 (5) 1800171; 10.1183/13993003.00171-2018
Year: 2018



MRI assessment of right atrial volume and function in pulmonary hypertension
Source: Annual Congress 2012 - Functional imaging of the lung parenchyma, tumours and circulation
Year: 2012

Comparing cardiac magnetic resonance imaging in group 1 and group 4 pulmonary hypertension
Source: Annual Congress 2011 - Physiology of human pulmonary hypertension
Year: 2011


Role of chest magnetic resonance imaging (MRI) in the assessment and follow up of patients with cystic fibrosis (CF)
Source: Annual Congress 2010 - Infection, inflammation and destruction
Year: 2010

Detection of right ventricular dysfunction by tissue Doppler imaging in asymptomatic patients with pulmonary sarcoidosis
Source: Eur Respir J 2011; 37: 212-215
Year: 2011


Oxygen-enhanced MRI of the lung in the assessment of chronic obstructive pulmonary disease
Source: Annual Congress 2006 - New modalities and application in imaging of the chest
Year: 2006